We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$330M
Cap. Flow %
8.14%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.2 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
K icon
Kellanova
K
+$269M
2
SRCL icon
Stericycle Inc
SRCL
+$141M
3
MRO icon
Marathon Oil Corporation
MRO
+$108M
4
CHX icon
ChampionX
CHX
+$103M
5
SPR icon
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN icon
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X icon
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BE icon
376
Bloom Energy
BE
$82.6B
$211K 0.01%
+20,000
New +$237K
2024 Q3
0 quarters
INSP icon
377
Inspire Medical Systems
INSP
$1.99B
$211K 0.01%
1,000
-3,585
-78% -$623K
2022 Q3
8 quarters
DV icon
378
DoubleVerify
DV
$2.11B
$211K 0.01%
+12,500
New +$238K
2024 Q3
0 quarters
LTC icon
379
LTC Properties
LTC
$2.29B
$210K 0.01%
5,716
-15,138
-73% -$549K
2023 Q1
6 quarters
MGNI icon
380
CALL
Magnite
MGNI
$3.64B
$198K ﹤0.01%
+107,000
New +$1.46M
2024 Q3
0 quarters
ERAS icon
381
Erasca
ERAS
$5.61B
$191K ﹤0.01%
+70,000
New +$197K
2024 Q3
0 quarters
BOLD icon
382
Boundless Bio
BOLD
$58.5M
$184K ﹤0.01%
+53,168
New +$193K
2024 Q3
0 quarters
EVLVW icon
383
DELISTED
Evolv Technologies Warrant
EVLVW
$182K ﹤0.01%
463,341
-14,900
-3% -$5.92K
2021 Q3
12 quarters
BGS icon
384
PUT
B&G Foods
BGS
$195M
$179K ﹤0.01%
117,500
– –
2023 Q1
6 quarters
IMUX icon
385
Immunic
IMUX
$112M
$178K ﹤0.01%
10,769
-1,000
-8% -$14.2K
2022 Q1
10 quarters
PTGX icon
386
CALL
Protagonist Therapeutics
PTGX
$9.3B
$164K ﹤0.01%
+40,000
New +$1.62M
2024 Q3
0 quarters
SVRA icon
387
Savara
SVRA
$1.01B
$163K ﹤0.01%
38,482
-5,496
-12% -$24.3K
2022 Q2
9 quarters
LVS icon
388
PUT
Las Vegas Sands
LVS
$23.4B
$158K ﹤0.01%
37,200
– –
2024 Q1
2 quarters
STWD icon
389
PUT
Starwood Property Trust
STWD
$4.7B
$157K ﹤0.01%
138,100
– –
2021 Q2
13 quarters
LYV icon
390
PUT
Live Nation Entertainment
LYV
$39.7B
$156K ﹤0.01%
215,400
– –
2023 Q3
4 quarters
OMF icon
391
PUT
OneMain Financial
OMF
$6.45B
$137K ﹤0.01%
30,500
– –
2022 Q3
8 quarters
ALT icon
392
Altimmune
ALT
$508M
$135K ﹤0.01%
22,048
-17,952
-45% -$122K
2023 Q4
3 quarters
CCCC icon
393
C4 Therapeutics
CCCC
$389M
$131K ﹤0.01%
+23,000
New +$138K
2024 Q3
0 quarters
CAR icon
394
CALL
Avis
CAR
$3.74B
$128K ﹤0.01%
+15,000
New +$1.35M
2024 Q3
0 quarters
AGEN icon
395
Agenus
AGEN
$346M
$125K ﹤0.01%
22,888
-52,301
-70% -$391K
2024 Q2
1 quarter
XBI icon
396
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$124K ﹤0.01%
135,000
+75,000
+125% +$7.37M
2023 Q3
4 quarters
UBX icon
397
DELISTED
Unity Biotechnology
UBX
$117K ﹤0.01%
79,354
+7,371
+10% +$10.8K
2022 Q3
8 quarters
DTIL icon
398
Precision BioSciences
DTIL
$185M
$114K ﹤0.01%
12,729
+1,183
+10% +$11.4K
2022 Q2
9 quarters
SLNO icon
399
CALL
DELISTED
Soleno Therapeutics
SLNO
$108K ﹤0.01%
+28,000
New +$1.34M
2024 Q3
0 quarters
XBI icon
400
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$106K ﹤0.01%
+70,000
New +$6.88M
2024 Q3
0 quarters
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.